The Motley Fool

TSX:GUD (KNIGHT THERAPEUTICS INC)

$6.98 $-0.01 (0.00) Tuesday, July 14, 2020 at 4:00:00 p.m. Eastern Daylight Time

About

Last updated Jul 14, 2020, 04:00:00pm EDT
Current Price $6.98
Today's Change $-0.01 (-0.1%)
Close Price $6.98
Open Price $6.98
Bid $6.94
Ask $7.00
Day Range $6.82 - $7.02
Year Range $4.73 - $8.88
Volume 217,898
Average Volume 252,220
Market Cap $915,259,541.00
EPS (ttm) $0.06

Related Articles

Top TSX Stocks Under $10

Markets have been somewhat volatile to close out this month, so investors should target TSX stocks that are on the cheaper side right now. More »

2 TSX Pharma Stocks That Can Make You a TFSA Millionaire

Here's why you can buy shares of Viemed Healthcare and Knight Therapeutics right now! More »

TFSA: 3 Healthcare Stocks That Can Make You Filthy Rich

TFSA investors should be on the hunt for the kind of growth offered by healthcare stocks like Knight Therapeutics Inc. (TSX:GUD) in 2020 and... More »

TFSA Investors: 2 Healthcare Stocks to Buy in May

It has been a wild 2020, but TFSA investors should target exciting healthcare stocks like Knight Therapeutics Inc. (TSX:GUD) to start the month of... More »

TFSA Investors: 2 Growth Stocks I’m Buying If the Market Selloff Gets Worse

During turbulent economic times, investors usually want to dial back risk and retreat to stable income vehicles. However, recent history has shown us how... More »

Canada’s Most Undervalued Pharmaceutical Stock Is a Buy!

Does the genius of CEO Jonathan Goodman of Knight Therapeutics Inc. (TSX:GUD) come for free? More »

Growth Investors: This Stock Could Easily Turn $10,000 Into $100,000

Jonathan Goodman and Knight Therapeutics Inc. (TSX:GUD) could be the market's next great growth story. Are you willing to let this opportunity pass? More »

Revealed: 5 Top Growth Picks From This Award-Winning Mutual Fund

One of Canada's best mutual funds is investing in small-cap growth companies like Freshii Inc. (TSX:FRII), Aritzia Inc. (TSX:ATZ), and Sierra Wireless, Inc. (TSX:SW)(NASDAQ:SWIR).... More »

5 Reasons Why This Pharma Stock Is Poised for Takeoff

Knight Therapeutics Inc. (TSX:GUD) has an effective low-risk strategy combined with one of the best balance sheets in the industry. More »

Can Knight Therapeutics Inc. Repeat the Success of Paladin Labs?

Knight Therapeutics Inc. (TSX:GUD) offers investors exposure to the lucrative specialty pharmaceutical market. More »